Abstract no : 1-3-DG-020
Author(s) : Thabrew, M.I.; Hughes, R.D
Address : Institute of Liver Studies, King’s College School of Medicine and Dentistry, Bessemer Road, London SE5 9PJ,UK
Source : Phytotherapy Research, v. 10(6): p. 451-467, 1996
Title : PHYTOGENIC AGENTS IN THE THERAPY OF LIVER DISEASE
Abstract : The clinical trials carried out with thirteen plants and their constituents in patients with liver disease, including acute viral hepatitis, chronic viral hepatitis, chronic cholecystitis, alcoholic liver disease and mushroom poisoning have been reviewed. Silymarin has been reported to exihibit the most proven overall clinical hepatoprotective effect while glycyrrhizin active fraction of G.glabra (Yastimadu) more beneficial in chronic viral hepatitis. With the high worldwide incidence of viral hepatitis, further study of isolated phytoch
Author(s) : Thabrew, M.I.; Hughes, R.D
Address : Institute of Liver Studies, King’s College School of Medicine and Dentistry, Bessemer Road, London SE5 9PJ,UK
Source : Phytotherapy Research, v. 10(6): p. 451-467, 1996
Title : PHYTOGENIC AGENTS IN THE THERAPY OF LIVER DISEASE
Abstract : The clinical trials carried out with thirteen plants and their constituents in patients with liver disease, including acute viral hepatitis, chronic viral hepatitis, chronic cholecystitis, alcoholic liver disease and mushroom poisoning have been reviewed. Silymarin has been reported to exihibit the most proven overall clinical hepatoprotective effect while glycyrrhizin active fraction of G.glabra (Yastimadu) more beneficial in chronic viral hepatitis. With the high worldwide incidence of viral hepatitis, further study of isolated phytoch
Comments
Post a Comment